LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Clinical trials for LUNG CANCER NON-SMALL CELL CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER NON-SMALL CELL CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for LUNG CANCER NON-SMALL CELL CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink tough lung cancers
Disease control Not yet recruitingThis Phase 2 trial tests a drug called ivonescimab, either alone or with chemotherapy, in people with advanced non-small cell lung cancer that has certain genetic changes. The study aims to see if the treatment can shrink tumors and control the cancer. About 46 participants will …
Matched conditions: LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a volunteer buddy help lung cancer patients feel better?
Symptom relief Not yet recruitingThis study is testing a program called Care and Connect, where trained volunteers provide support and information to people with lung cancer. The goal is to see if this program helps reduce distress and makes it easier for patients to get the care they need. About 50 adults with …
Matched conditions: LUNG CANCER NON-SMALL CELL CANCER (NSCLC)
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC